Global Depression Drugs Market 2015 Trends, Demand, Growth & Forecast to 2019

1. Top 10 Diabetes Care Technologies, Devices and Therapeutics Markets - Growth, Global Share, Industry Overview, Analysis, Trends Opportunities and Forecast 2012 - 2020 Global Depression Drugs Market 2015-2019 Growth, Global Share, Industry Overview, Analysis, Trends Opportunities and Forecast

2. Description Report Overview About depression drugs According to the WHO, depression is a common mental disorder that contributes significantly to the global burden of disease. It affects people across communities worldwide. It is characterized by sadness, loss of interest or pleasure, feelings of guilt or low self-worth, disturbed sleep or appetite, feelings of tiredness, and poor concentration. Depression can be roughly categorized into six different types. According to a 2012 estimate by the WHO, about 3,000 suicides take place each day, resulting in more than a million deaths each year. Depression can be recurrent and can be severely debilitating. Patients with mild depression can be treated with medications, but in cases of moderate or severe depression, the patient needs both medication and professional psychotherapy in the form of counseling. The global depression drugs market to grow at a CAGR of 5.25% over the period 2014-2019. Read more details at:http://www.bigmarketresearch.com/global-depression-drugs-2015-2019-market

3. Key Benefits Summery Global Depression Drugs Market report covers the present scenario and the growth prospects of the global depression drugs market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used for the treatment of depression. The global depression drugs market is segmented based on the mechanism of action of the drugs used to treat depression, as mentioned below: • Tricyclic antidepressants • Serotonin-norepinephrine reuptake inhibitors • Selective serotonin reuptake inhibitors • Monoamine oxidase inhibitors • Others Global Depression Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, EMEA, and APAC; it also covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

4. Key Audiences Key regions • Americas • APAC • EMEA Key vendors • Actavis • Bristol-Myers Squibb • Eli Lilly • GlaxoSmithKline Other prominent vendors • Abbott Laboratories • Addex Therapeutics • Alkermes • AstraZeneca • AurobindoPharma • Avanir Pharmaceuticals • Cerecor • Chugai Pharmaceutical

5. Table Of Contents Market Trends: Market driver • Rise in patient population • For a full, detailed list, view our report Market challenge • Threat of expiry of patents • For a full, detailed list, view our report Market trend • Growing public awareness • For a full, detailed list, view our report Enquire About Report:http://www.bigmarketresearch.com/report-enquiry/250594

6. Get Full Information At: http://www.bigmarketresearch.com/global-depression-drugs-2015-2019-market